Controversies in circulating tumor cell count during therapy

Author： Raimondi Cristina Gradilone Angela Gazzaniga Paola

ISSN： 1473-7159

Source： Expert Review of Molecular Diagnostics, Vol.13, Iss.5, 2013-06, pp. : 499-507

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating Tumor Cells in Cancer Therapy: Are we off Target?

Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. : 509-518

Bentham Science Publishers

Access to resources Recommend Favorite

Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non–small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: Pilot study results

By Dorsey Jay F. Kao Gary D. MacArthur Kelly M. Ju Melody Steinmetz David Wileyto E. Paul Simone Charles B. Hahn Stephen M.

Cancer, Vol. 121, Iss. 1, 2015-01 ,pp. : 139-149

Blackwell Publishing

Access to resources Recommend Favorite

Controversies in breast cancer: adjuvant and neoadjuvant therapy

By Montemurro Filippo Redana Stefania Valabrega Giorgio Aglietta Massimo

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1055-1072

Informa Healthcare

Access to resources Recommend Favorite

Controversies of Androgen Ablation Therapy for Metastatic Prostate Cancer

Current Pharmaceutical Design, Vol. 12, Iss. 7, 2006-03 ,pp. : 799-805

Bentham Science Publishers

Access to resources Recommend Favorite

Controversies in Anticoagulant Therapy in Vitreo-Retinal Surgery

Current Pharmaceutical Design, Vol. 21, Iss. 32, 2015-10 ,pp. : 4661-4666

Bentham Science Publishers

Access to resources Recommend Favorite